RECRUITING

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Description

The study team hypothesizes that it is feasible to intraoperatively detect tumor following \[CU64\]DOTATATE injection using the gamma probe device.

Conditions

Meningioma
Talk to us

Related Conditions:

Meningioma

Study Overview

On this page

Study Details

Study overview

The study team hypothesizes that it is feasible to intraoperatively detect tumor following \[CU64\]DOTATATE injection using the gamma probe device.

A Pilot Study to Evaluate Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Condition
Meningioma
Intervention / Treatment

-

Contacts and Locations

New York

New York-Presbyterian/Weill Cornell Medical Center, New York, New York, United States, 10021

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * High suspicion of meningioma necessitating surgical resection based on conventional MRI criteria, or diagnosis of meningioma based on pathology reports from prior resection with radiographic findings of suspected recurrent or residual tumor necessitating repeat surgery.
  • * Pregnant or breastfeeding
  • * Patients undergoing endoscopic endonasal resection, eyebrow incision surgery, or any surgical procedure in which the neoprobe cannot be employed
  • * Patients with hypersensitivity to somatostatin analogs
  • * Patients with contraindications to conventional MRI
  • * Patients with prior history of cranial radiation therapy
  • * Patients currently enrolled in other therapeutic clinical trials related to meningioma will be excluded

Ages Eligible for Study

18 Years to 99 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Weill Medical College of Cornell University,

Jana Ivanidze, MD/PhD, PRINCIPAL_INVESTIGATOR, Weill Medical College of Cornell University

Study Record Dates

2025-01